Eppen_TracePCR_Dec24
  Editorial
 THE INDIAN PHARMACOPOEIA 2026   
 Wednesday, January 7, 2026 
 On January 2, 2026, the Union Health Ministry has released the Indian Pharmacopoeia 2026 (IP-2026) which is the 10th edition of India’s official book of drug standards, marking a significant milestone in India’s ongoing 
  Past Editorial...  
TODAY'S NEWS
15:15  [IST]Health ministry notifies recruitment of 2 more drug inspectors
15:00  [IST]US FDA accepts Camurus’ resubmission of NDA for Oclaiz for treatment of acromegaly
14:30  [IST]Alembic Pharmaceuticals receives US FDA tentative approval for Bosutinib tablets
14:15  [IST]Aragen unveils CHOMax, an accelerated platform for DNA to IND-enabling clinical supply in 10 months
14:00  [IST]Cycle Pharma and Inceptua expand Free Goods Programme for patients with hereditary tyrosinemia type 1 and Alkaptonuria to Include Morocco & Egypt
13:45  [IST]Manipal Hospital Gurugram launches ‘Kawach’, a community-health screening programme
more news >>
TOP NEWS
08:00  [IST]DoP calls for proposals to set up common facilities for medical device clusters
08:00  [IST]MSMEs need handholding to implement online submission of CDSCO mandated WHO-GMP CoPP: BDMAI
08:00  [IST]CDSCO’s recent labelling reforms a constructive step towards building a more globally aligned ecosystem: Expert
08:00  [IST]Telangana DCA’s 2025 annual action taken report highlights expansion of enforcement & global regulatory synergy
08:00  [IST]Imports of bulk drugs and intermediates decline 2.8% in November
08:00  [IST]Panel asks Ayush Ministry to come out with detailed strategic plans to achieve $200 billion market capitalisation
more news >>
YESTERDAY'S NEWS
18:00  [IST]4Moving Biotech receives US FDA’s IND clearance for 4P004; strengthens its position as a leading innovator in disease-modifying osteoarthritis therapeutics
17:00  [IST]US FDA grants fast track designation to Complement Therapeutics’ gene therapy candidate CTx001 to treat geographic atrophy
16:00  [IST]MRM Health receives US FDA IND clearance to initiate phase 2b trial of MH002 in mild-to-moderate ulcerative colitis
15:00  [IST]PharmaForceIQ acquires Aktana to deliver unparalleled cross-functional engagement impact for pharma sector
14:00  [IST]NRG Therapeutics doses its first-in-human phase 1 trial for NRG5051 to treat ALS/MND and Parkinson’s disease
13:00  [IST]Vanda Pharma announces receipt of US FDA decision letter on Hetlioz sNDA for jet lag disorder
more news >>
INTERVIEW  
Haryana DC targets 100% Schedule M compliance in MSME sector through risk-based audits and continuous training
Lalit Kumar Goel, State Drug Controller (SDC) of Haryana
Past Interviews...
 
  What's New?  
 
Opinion Poll
 
 
Will the introduction of Revised Schedule M by Union Health Ministry solve the issue of quality of Indian drugs?
  
 
 
   
 
  Corporate
Pharma Stocks
Executive Diary
Pharma People
Product Launches
  Special Features
Features
  Chronicle Pharmabiz Specials
Forthcoming
  Past
 
  Forthcoming Events
International
  Domestic
 
TENDERS & PROJECTS
Tenders & Enquiries
Pharma Projects
CORPORATE
Company Profile
Corporate Results
Corporate X-ray
Pharmabiz Studies of Top Companies
US FDA UPDATE
US FDA: ANDA
US FDA: Warnings
US FDA: Approved NMEs
US FDA: New Approvals
EXPORT & IMPORT
Drug Export Procedures
Drug Units With WHO GMP Certification
Pharma Export Data
Import Reg. Update
PHARMA LAWS & DOCUMENTS
Notifications
Pharma Regulations
Patent Laws and Amendments
Patent Scan
Documents
New Drug Approvals
Notified Prices
LIST OF LABS & GOVT. BODIES
Govt Recognised In-House R&D Units
AICTE Boards & Committees
List of Indian CROs
List of CROs (International)
Govt & approved labs of India
List of State Drugs Controllers
 
 
Avians_2025
                                                         
Copyright © 2024 Saffron Media Pvt. Ltd | twitter
 
linkedin
 
 
linkedin
 
instagram